- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cumberland Pharmaceuticals Inc (CPIX)
Assess today's live Cumberland Pharmaceuticals Inc (CPIX) share price, performance and insights using our live NASDAQ: CPIX stock exchange data.
Analyse the historical data and Cumberland Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Cumberland share price buy/sell indicators using real-time data (or discuss the Cumberland (CPIX) stock price today with other investors in the Cumberland NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CPIX share price (ISIN: US2307701092) to enhance your trading decisions with our free investment tools and resources.
What Is the Cumberland Pharmaceuticals Inc Share Price Today?
The Cumberland share price today is 4.260.
What Is the Stock Symbol for Cumberland Pharmaceuticals Inc
The stock symbol (or 'ticker') for Cumberland Pharmaceuticals Inc is "CPIX."
What Stock Exchange Does Cumberland Pharmaceuticals Inc Trade On?
Cumberland Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Cumberland Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Cumberland Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Cumberland Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Cumberland share price buy/sell indicators using real-time data (or discuss the Cumberland (CPIX) stock price today with other investors in the Cumberland NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CPIX share price (ISIN: US2307701092) to enhance your trading decisions with our free investment tools and resources.
What Is the Cumberland Pharmaceuticals Inc Share Price Today?
The Cumberland share price today is 4.260.
What Is the Stock Symbol for Cumberland Pharmaceuticals Inc
The stock symbol (or 'ticker') for Cumberland Pharmaceuticals Inc is "CPIX."
What Stock Exchange Does Cumberland Pharmaceuticals Inc Trade On?
Cumberland Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Cumberland Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Cumberland Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.930
4.330
52 wk Range
1.850
7.250
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.9304.330
52 wk Range
1.8507.250
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CPIX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Cumberland Company Profile
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, an injection for the prevention of nausea and vomiting for patients receiving chemotherapy treatment; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of the cardiomyopathy associate with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, and aspirin-exacerbated respiratory disease; and is in Phase II clinical trial for the treatment of systemic sclerosis and idiopathic pulmonary fibrosis. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Cumberland Pharmaceuticals Inc Earnings Call Summary for Q3/2025
- Cumberland Pharmaceuticals reported Q3 2025 revenue of $8.3 million with 12% year-to-date growth, despite an adjusted loss of $0.06 per share, leading to a 3.62% stock decline.
- The company expanded internationally with Vibativ's launch in Saudi Arabia and Caldolor's approval in Mexico, while forming a new partnership with RedHill Biopharma for Talicia.
- Financial position remains stable with $15.2 million in cash and cash equivalents and total assets of $66 million, despite the quarterly adjusted loss of $0.8 million.
- CEO A.J. Kazimi forecasts stronger Q4 2025 performance driven by approved brands, international market contributions, and progress in Ifetroban clinical programs for conditions like Duchenne muscular dystrophy.
Last Updated: 04/11/2025, 22:20
Read Full TranscriptCompare CPIX to Peers and Sector
Metrics to compare | CPIX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCPIXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −19.1x | −3.2x | −0.6x | |
PEG Ratio | −0.28 | 0.14 | 0.00 | |
Price/Book | 2.4x | −0.9x | 2.6x | |
Price / LTM Sales | 1.5x | 1.7x | 3.2x | |
Upside (Analyst Target) | - | 125.7% | 41.8% | |
Fair Value Upside | Unlock | 27.3% | 5.1% | Unlock |
Earnings
Latest Release
Nov 04, 2025
EPS / Forecast
-0.06 / --
Revenue / Forecast
8.30M / --
People Also Watch
FAQ
What Is the Cumberland (CPIX) Share Price Today?
The live Cumberland share price today is 4.260
What Stock Exchange Does Cumberland (CPIX) Trade On?
Cumberland is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Cumberland?
The stock symbol (also called a 'ticker') for Cumberland is "CPIX."
What Is the Current Cumberland Market Cap?
As of today, Cumberland market capitalisation is 63.72M.
What Is Cumberland's (CPIX) Earnings Per Share (TTM)?
The Cumberland EPS is currently -0.23 (Trailing Twelve Months).
When Is the Next Cumberland Earnings Date?
Cumberland's next earnings report will be released on 10 Mar 2026.
Is CPIX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Cumberland moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Cumberland Stock Split?
Cumberland has split 0 times. (See the CPIX stock split history page for full effective split date and price information.)
How Many Employees Does Cumberland Have?
Cumberland has 91 employees.
What is the current trading status of Cumberland (CPIX)?
As of 24 Dec 2025, Cumberland (CPIX) is trading at a price of 4.260, with a previous close of 4.350. The stock has fluctuated within a day range of 3.930 to 4.330, while its 52-week range spans from 1.850 to 7.250.
What Is the CPIX After Hours Price?
CPIX's last after hours stock price is 4.280, the stock has decreased by 0.020, or 0.470%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.